Novo NordiskNVO 
$87.37-0.32%24h
-0.32%24h
Global rank24
Market cap$391.66B
Change 7d-20.06%
YTD Performance-
SP500 benchmark
P/E4.69
P/S12.11
Revenue$32.35B
Earnings$11.66B
Dividend yield1.1%
Main Sector
Healthcare
Category
Novo Nordisk (NVO) Cash on Hand
NVO Cash on Hand in 2022: $4.21B
According to Novo Nordisk latest financial reports the cash on hand of NVO is $4.21B, an increase of 28.23% to 2022. At the end of 2022 company had $3.28B cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
NVO Cash on Hand History from 2018 to 2023
-
Value:-
NVO Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $4.21B | 28.23% |
| 2022 | $3.28B | 34.82% |
| 2021 | $2.44B | 37.06% |
| 2020 | $1.78B | -17.56% |
| 2019 | $2.16B | -1.04% |
| 2018 | $2.18B | - |
View the Top Cash on Hand Companies 
